How long does a course of avatrombopag last?

The maintenance time of a course of avatrombopag varies due to individual differences and different conditions, but generally a course of treatment refers to a period of continuous taking of the drug to achieve the purpose of treatment.

Avatrombopag is an oral immunosuppressant that can stimulate the body's hematopoietic stem cells and enhance the body's immunity. It is mainly used to treat thrombocytopenia. This drug can cause a dose-dependent increase in platelet counts in adults and is effective in the treatment of thrombocytopenia caused by immune thrombocytopenia, chronic liver disease, or tumor disease.

Typically, the course of treatment with avatrombopag is5 days. During this 5 days of treatment, most patients 3 to 5 after the start of treatment Increases in platelet counts are observed within days, with peak platelet elevations typically occurring between 10 and 13 days after treatment. However, due to differences in personal physique and condition, the specific effective time and course of treatment will vary.

Clinical data shows that some patients with thrombocytopenia begin to increase their platelets on the 8th day after taking avatrombopag, and some patients can even achieve sustained responses. However, it is important to note that the time and degree of response may vary from patient to patient.

After treatment with avatrombopag, the increase in platelet count usually persists for some time. Most patients can maintain their platelet count at a high level for 3 to 5 days after taking it according to the course of treatment. However, due to individual differences, some patients may only be able to maintain it for 1 to 3 days.

For different causes of thrombocytopenia, such as primary or secondary, the time required for treatment and the effectiveness of drugs will also vary. Essential thrombocytopenia may require long-term medication, whereas secondary thrombocytopenia may require relatively short-term treatment.